Terms: = Head and neck cancer AND CCDC6, D10S170, 8030, ENSG00000108091, Q16204, TPC, H4, TST1 AND Prognosis
69 results:
1. AKR1C3 silencing inhibits autophagy-dependent glycolysis in thyroid cancer cells by inactivating ERK signaling.
Gao Y; Tao W; Wang S; Duan R; Zhang Z
Drug Dev Res; 2024 Feb; 85(1):e22142. PubMed ID: 38349266
[TBL] [Abstract] [Full Text] [Related]
2. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
3. Analysis of B7-H4 Expression Across Salivary Gland Carcinomas Reveals Adenoid Cystic Carcinoma-Specific Prognostic Relevance.
Siqueira JM; Mitani Y; Hoff CO; Bonini F; Guimaraes de Sousa L; Marques-Piubelli ML; Purushothaman A; Mitani M; Dai H; Lin SY; Spiotto MT; Hanna EY; McGrail DJ; El-Naggar AK; Ferrarotto R
Mod Pathol; 2024 Jan; 37(1):100371. PubMed ID: 38015043
[TBL] [Abstract] [Full Text] [Related]
4. MEX3A induces the development of thyroid cancer via targeting CREB1.
Feng G; Wang P; Zhang H; Cheng S; Xing Y; Wang Y
Cell Biol Int; 2023 Nov; 47(11):1843-1853. PubMed ID: 37529875
[TBL] [Abstract] [Full Text] [Related]
5. Spatial Immunoprofiling of Adenoid Cystic Carcinoma Reveals B7-H4 Is a Therapeutic Target for Aggressive Tumors.
Sousa LG; McGrail DJ; Lazar Neto F; Li K; Marques-Piubelli ML; Ferri-Borgogno S; Dai H; Mitani Y; Spardy Burr N; Cooper ZA; Kinneer K; Cortez MA; Lin SY; Bell D; El Naggar A; Burks J; Ferrarotto R
Clin Cancer Res; 2023 Aug; 29(16):3162-3171. PubMed ID: 37256648
[TBL] [Abstract] [Full Text] [Related]
6. Clinical Impact of androgen Receptor-Suppressing miR-146b Expression in Papillary Thyroid cancer Aggressiveness.
Chou CK; Chi SY; Hung YY; Yang YC; Fu HC; Wang JH; Chen CC; Kang HY
J Clin Endocrinol Metab; 2023 Oct; 108(11):2852-2861. PubMed ID: 37220080
[TBL] [Abstract] [Full Text] [Related]
7. MicroRNA-130a-3p impedes the progression of papillary thyroid carcinoma through downregulation of KPNB1 by targeting PSME3.
Wang Y; Xu J; Zhu X; Kuang H
Endocrine; 2023 Oct; 82(1):96-107. PubMed ID: 37166548
[TBL] [Abstract] [Full Text] [Related]
8. TESC promotes differentiated thyroid cancer development by activating ERK and weakening NIS and radioiodine uptake.
Guo Y; Cai Y; Song F; Zhu L; Hu Y; Liu Y; Ma W; Ge J; Zeng Q; Ding L; Li L; Zheng G; Ge M
Endocrine; 2023 Sep; 81(3):503-512. PubMed ID: 37020077
[TBL] [Abstract] [Full Text] [Related]
9. STC2 activates PRMT5 to induce radioresistance through DNA damage repair and ferroptosis pathways in esophageal squamous cell carcinoma.
Jiang K; Yin X; Zhang Q; Yin J; Tang Q; Xu M; Wu L; Shen Y; Zhou Z; Yu H; Yan S
Redox Biol; 2023 Apr; 60():102626. PubMed ID: 36764215
[TBL] [Abstract] [Full Text] [Related]
10. Three-dimensional genome landscape comprehensively reveals patterns of spatial gene regulation in papillary and anaplastic thyroid cancers: a study using representative cell lines for each cancer type.
Zhang L; Xu M; Zhang W; Zhu C; Cui Z; Fu H; Ma Y; Huang S; Cui J; Liang S; Huang L; Wang H
Cell Mol Biol Lett; 2023 Jan; 28(1):1. PubMed ID: 36609218
[TBL] [Abstract] [Full Text] [Related]
11. An integrative pan cancer analysis of RET aberrations and their potential clinical implications.
Zhou L; Li J; Zhang X; Xu Z; Yan Y; Hu K
Sci Rep; 2022 Aug; 12(1):13913. PubMed ID: 35978072
[TBL] [Abstract] [Full Text] [Related]
12. Inhibition of DNMT1 potentiates antitumor immunity in oral squamous cell carcinoma.
Yang SC; Wang WY; Zhou JJ; Wu L; Zhang MJ; Yang QC; Deng WW; Sun ZJ
Int Immunopharmacol; 2022 Oct; 111():109113. PubMed ID: 35944462
[TBL] [Abstract] [Full Text] [Related]
13. The prognostic impact of B7-H3 and B7-H4 in head and neck squamous cell carcinoma.
Borgmann M; Oetting A; Meyer F; Möckelmann N; Droste C; von Bargen CM; Möller-Koop C; Witt M; Borgmann K; Rothkamm K; Betz C; Münscher A; Clauditz TS; Rieckmann T
J Cancer Res Clin Oncol; 2023 Jul; 149(7):3383-3393. PubMed ID: 35941227
[TBL] [Abstract] [Full Text] [Related]
14. NOD1 activation promotes cell apoptosis in papillary thyroid cancer.
Bai N; Liu C; Zhang X; Cheng Y; Hou D
Pathol Res Pract; 2022 May; 233():153880. PubMed ID: 35430507
[TBL] [Abstract] [Full Text] [Related]
15. Machine learning algorithms are comparable to conventional regression models in predicting distant metastasis of follicular thyroid carcinoma.
Mao Y; Lan H; Lin W; Liang J; Huang H; Li L; Wen J; Chen G
Clin Endocrinol (Oxf); 2023 Jan; 98(1):98-109. PubMed ID: 35171531
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-99a-3p/GRP94 axis affects metastatic progression of human papillary thyroid carcinoma by regulating ITGA2 expression and localization.
Gao Y; Pan Y; Wang T; Yao Y; Yuan W; Zhu X; Wang K
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1650-1661. PubMed ID: 34687203
[TBL] [Abstract] [Full Text] [Related]
17. A 6 transcription factors-associated nomogram predicts the recurrence-free survival of thyroid papillary carcinoma.
Wang T; Tian K; Ji X; Song F
Medicine (Baltimore); 2021 Oct; 100(40):e27308. PubMed ID: 34622829
[TBL] [Abstract] [Full Text] [Related]
18. Diverse Oncogenic Fusions and Distinct Gene Expression Patterns Define the Genomic Landscape of Pediatric Papillary Thyroid Carcinoma.
Stosic A; Fuligni F; Anderson ND; Davidson S; de Borja R; Acker M; Forte V; Campisi P; Propst EJ; Wolter NE; Chami R; Mete O; Malkin D; Shlien A; Wasserman JD
Cancer Res; 2021 Nov; 81(22):5625-5637. PubMed ID: 34535459
[TBL] [Abstract] [Full Text] [Related]
19. Hypoxia-inducible factor-1α cooperates with histone Lys methylation to predict prognosis in esophageal squamous cell carcinoma.
Shen X; Li Y; Xu Y; Liu M; Zhang Q; Yin R; Zhou M; Lin S; Fan H
Biomark Med; 2021 May; 15(7):509-522. PubMed ID: 33856264
[No Abstract] [Full Text] [Related]
20. miR-1301-3p suppresses tumor growth by downregulating PCNA in thyroid papillary cancer.
Qiao DH; He XM; Yang H; Zhou Y; Deng X; Cheng L; Zhou XY
Am J Otolaryngol; 2021; 42(2):102920. PubMed ID: 33454555
[TBL] [Abstract] [Full Text] [Related]
[Next]